Healthcare Global Enterprises Limited has informed the Exchange that Board of Directors at its meeting held on February 24, 2026, has decided to issue equity shares on rights basis in the ratio of 1: 17 (1 Rights Equity Share for every 17 fully paid-up equity shares), to eligible equity shareholders, held as on the Record Date being March 02, 2026 at an Issue Price of Rs. 512 per share.
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.7 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
HCG's board, at its meeting on February 24, 2026, approved a Rights Issue of up to ₹42,468.18 Lakhs, comprising 82,94,566 fully paid-up equity shares of face value ₹10 each. The issue price is fixed at ₹512 per share, which includes a premium of ₹502. Eligible shareholders will get 1 Rights Equity Share for every 17 shares held on the record date of March 02, 2026. The issue opens on March 11, 2026 and closes on March 25, 2026, with listing expected by April 1, 2026. Post-issue, the total equity share count will rise from 141,007,637 to 149,302,203 (assuming full subscription), implying about a 5.9% increase in share base.
Existing shareholders will need to decide whether to invest additional capital or let their rights entitlements lapse, with the issue price carrying a significant premium over face value. Short-term share price may face dilution pressure, but the fundraising strengthens the company's capital base for growth.